Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ark Genomic Revolution ETF (ARKG)

Ark Genomic Revolution ETF (ARKG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 2,130,136,600
  • Market Capitalization, $K 2,130,137
  • Shares Outstanding, K 35,455
  • 60-Month Beta 1.65
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 2.11 (3.38%)
  • Most Recent Dividend 2.108 on 12/27/19
  • Management Fee 0.75%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.80 +18.09%
on 09/04/20
63.17 -1.30%
on 09/18/20
+1.29 (+2.11%)
since 08/25/20
3-Month
49.63 +25.63%
on 06/29/20
64.34 -3.09%
on 08/24/20
+9.90 (+18.88%)
since 06/25/20
52-Week
24.00 +159.79%
on 03/18/20
64.34 -3.09%
on 08/24/20
+31.93 (+104.96%)
since 09/25/19

Most Recent Stories

More News
How Will Biotech ETFs React to Vaccine Makers' Safety Pledge?

Nine vaccine developers have jointly pledged to observe high ethical standards in conducting clinical studies and manufacturing of vaccines.

IBB : 133.47 (+2.13%)
XBI : 110.81 (+2.54%)
BBH : 158.74 (+2.39%)
FBT : 155.15 (+1.80%)
ARKG : 62.35 (+3.71%)
Biotech ETFs to Shine Bright on Coronavirus Vaccine Progress

AstraZeneca's initiation of a phase III study has heated up competition to bring a coronavirus vaccine to the markets.

AZN : 55.51 (+2.47%)
IBB : 133.47 (+2.13%)
XBI : 110.81 (+2.54%)
BBH : 158.74 (+2.39%)
FBT : 155.15 (+1.80%)
ARKG : 62.35 (+3.71%)
Top-Performing ETFs of Last Week

Wall Street was moderate last week with the S&P 500 and the Nasdaq gaining about 0.7% and 2.7%, respectively, and the Dow Jones witnessing no movement.

PEZ : 61.85 (+1.92%)
TAPR : 82.25 (unch)
BLCN : 33.63 (+0.24%)
ARKG : 62.35 (+3.71%)
FNGS : 91.72 (+2.37%)
5 Outperforming ETFs That Pay Dividends

Investors should consider dividend-paying ETFs. ETFs reduce risk, and dividends provide a cushion if the recovery slows or reverses. XLK, SMH, SIL, ARKG, and ICLN are five intriguing options. The...

XLK : 113.94 (+2.39%)
SMH : 169.24 (+1.16%)
SIL : 42.35 (-1.37%)
ARKG : 62.35 (+3.71%)
ICLN : 16.80 (+2.19%)
5 Sector ETFs That Have Gained More Than 50% This Year

We highlight five ETFs from different sectors of the broad market that have outperformed and gained at least 50% so far this year.

HERO : 26.95 (+1.13%)
TAN : 57.64 (+3.35%)
ARKW : 106.00 (+2.91%)
ARKG : 62.35 (+3.71%)
ONLN : 61.63 (+1.97%)
New GERM ETF Launched to Tap the Growing Biotech Sector

GERM invests in the hottest emerging biotechnology trends.

MRNA : 69.47 (+6.60%)
ALNY : 138.31 (+3.73%)
BIO : 504.15 (+2.02%)
SBIO : 40.66 (+2.42%)
PBE : 55.90 (+1.77%)
ARKG : 62.35 (+3.71%)
How Are Biotech ETFs Reacting to Coronavirus Treatment News?

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

GILD : 62.25 (unch)
LLY : 150.26 (+0.97%)
IBB : 133.47 (+2.13%)
XBI : 110.81 (+2.54%)
BBH : 158.74 (+2.39%)
FBT : 155.15 (+1.80%)
ARKG : 62.35 (+3.71%)
5 ETFs Up More Than 20% in Three Months

Wall Street has been performing impressively with the major indices climbing to a 12-week high. The rally was mainly powered by optimism over a potential coronavirus vaccine as well as an uptick in the...

SGDM : 32.90 (-0.75%)
IBUY : 86.96 (+2.13%)
ARKG : 62.35 (+3.71%)
WCLD : 42.16 (+3.31%)
URNM : 29.26 (+1.11%)
Biotech ETFs Soaring on COVID-19 Vaccine Progress

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

JNJ : 145.66 (+0.68%)
AZN : 55.51 (+2.47%)
MRNA : 69.47 (+6.60%)
NVAX : 113.56 (+10.86%)
IBB : 133.47 (+2.13%)
XBI : 110.81 (+2.54%)
BBH : 158.74 (+2.39%)
FBT : 155.15 (+1.80%)
ARKG : 62.35 (+3.71%)
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain

The COVID-19 pandemic has kept biotech players all over the world on their toes for a vaccine. This new opportunity has made the sector the most attractive one to investors.

JNJ : 145.66 (+0.68%)
SNY : 50.78 (-0.02%)
PFE : 36.05 (+0.81%)
MRK : 82.93 (-0.26%)
MRNA : 69.47 (+6.60%)
GSK : 37.80 (+1.12%)
NVAX : 113.56 (+10.86%)
IBB : 133.47 (+2.13%)
XBI : 110.81 (+2.54%)
BBH : 158.74 (+2.39%)
BBC : 38.84 (+2.72%)
ARKG : 62.35 (+3.71%)
BNTX : 66.69 (+6.14%)
GNOM : 17.76 (+2.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ARKG with:

Fund Summary

The ARK Genomic Revolution ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials,...

See More

Top 10 Holdings

Name % Holdings
CRISPR THERAPEUTICS AG 9.33%
Invitae Corp 8.54%
ILLUMINA INC 8.31%
Compugen Ltd 7.32%
ARCTURUS THERAPEUTICS HOLDIN 6.38%
Intellia Therapeutics Inc 5.13%
Iovance Biotherapeutics Inc 4.08%
EDITAS MEDICIN 3.66%
CareDx Inc 3.54%
Cellectis SA 3.33%

See More

Key Turning Points

2nd Resistance Point 64.09
1st Resistance Point 63.22
Last Price 62.35
1st Support Level 60.71
2nd Support Level 59.06

See More

52-Week High 64.34
Last Price 62.35
Fibonacci 61.8% 48.93
Fibonacci 50% 44.17
Fibonacci 38.2% 39.41
52-Week Low 24.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar